Welcome to our dedicated page for Wiley (JOHN) & Sons SEC filings (Ticker: WLYB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The John Wiley & Sons, Inc. (WLYB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into Wiley’s financial performance, capital allocation decisions, governance, and strategic priorities in research publishing, research intelligence, learning solutions, and AI-related initiatives.
Among the most closely watched filings for WLYB are Form 10-K annual reports and Form 10-Q quarterly reports, which contain segment information for Research and Learning, discussions of demand to publish, read, and license content, and commentary on open access models, AI licensing revenue, and market conditions in academic and professional learning. Investors can also review how Wiley presents non-GAAP measures such as Adjusted EPS, Adjusted Operating Income and Margin, Adjusted EBITDA and Margin, and Free Cash Flow, along with reconciliations to GAAP figures.
Current reports on Form 8-K for WLYB document material events such as quarterly earnings announcements, increases in share repurchase allocations under the company’s authorization, dividend changes, Board appointments, and executive leadership updates. These filings often reference press releases that describe trends in research growth, AI momentum, and margin expansion, as well as decisions on dividends and repurchases.
Definitive proxy statements on Form DEF 14A provide information about Wiley’s Board of Directors, executive compensation, governance practices, and the company’s long-term mission to provide must-have knowledge and insights while embracing responsible AI. Together, these filings help investors understand how Wiley manages its Research and Learning businesses, approaches capital allocation, and positions itself within the scholarly and information ecosystem.
On Stock Titan, WLYB filings are supplemented with AI-powered summaries designed to make complex disclosures more accessible. These summaries can help readers quickly interpret key points from lengthy 10-K and 10-Q reports, 8-K event disclosures, and proxy materials, while links to the original EDGAR documents preserve full detail for deeper analysis.
Clarkston Capital Partners and related entities have filed a Schedule 13G reporting beneficial ownership of 2,617,945 shares of John Wiley & Sons, Inc. Class A Common Stock, representing 5.98% of the class, based on 43,792,357 shares outstanding as of November 30, 2025.
The filing attributes 1,020,000 shares with sole voting and dispositive power and 1,587,395–1,597,945 shares with shared voting and dispositive power for each reporting person. The shares are held in discretionary client accounts or an account of a control person of Clarkston Capital Partners.
The reporting group certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of John Wiley & Sons, Inc.
John Wiley & Sons, Inc. 10% owner Deborah E. Wiley reported selling 75,000 shares of Class A common stock on January 9, 2026. The shares were sold back to the company in a private transaction under a Board-approved repurchase program as part of her estate planning. The price was $30.5287 per share, based on the five-day volume-weighted average price ending January 8, 2026.
After the sale, she held 659,529 Class A shares directly. She also had indirect beneficial ownership of additional Class A shares held through several entities and a trust, including 1,200,000 shares via WG6 LLC, 462,338 shares via EPH LLC, 301,645 shares via WBW LP, and 55,673 shares as co-trustee.
John Wiley & Sons, Inc. reported that it has increased its Fiscal 2026 share repurchase allocation to $100 million. This planned buyback level is higher than the Company’s prior allocations of $60 million for Fiscal 2025 and $45 million for Fiscal 2024, indicating a larger capital return program for the coming fiscal year. The increase is being made under an existing $250 million share repurchase authorization approved by the Board on June 25, 2025, which provides the overall framework within which these repurchases may occur.
John Wiley & Sons, Inc. reported slightly lower revenue but higher profitability for the quarter ended October 31, 2025. Net revenue was $421.8 million, down modestly from $426.6 million a year ago, while net income rose to $44.9 million from $40.5 million as cost of sales and operating expenses declined. Diluted earnings per share increased to $0.84 from $0.74.
The Research segment drove results, with revenue of $278.5 million, led by Research Publishing at $241.4 million, while Learning revenue declined to $143.2 million as Academic and Professional products softened. Operating income improved to $73.0 million versus $64.1 million.
Operating cash flow for the six months was a use of $76.5 million, improving from a $94.0 million use, helped by working capital but offset by large reductions in contract liabilities. Wiley realized $114.1 million of cash proceeds from asset and business sales, including monetizing University Services notes and earnouts, and recorded a $3.4 million net loss on divestitures year-to-date. The multiyear Global Restructuring Program continued, with $6.1 million in restructuring and related charges in the quarter and total program charges reaching $148.9 million.
John Wiley & Sons, Inc. reported that it released its financial results for the second quarter of fiscal year 2026 and discussed them on an earnings conference call, both held on December 4, 2025. The company furnished a press release titled “Research Growth, AI Momentum, and Material Margin Expansion Highlight Wiley’s Second Quarter 2026” as Exhibit 99.1 and the related presentation materials as Exhibit 99.2. These materials are provided for informational purposes and are designated as furnished, not filed, under the securities laws.
The Vanguard Group filed Amendment No. 14 to Schedule 13G reporting beneficial ownership in John Wiley & Sons Inc (WLY) as of 09/30/2025. Vanguard reported 4,815,296 shares of common stock, representing 10.83% of the class.
Vanguard reported 0 shares with sole voting power and 279,047 shares with shared voting power. It reported 4,491,283 shares with sole dispositive power and 324,013 shares with shared dispositive power. Vanguard stated the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Vanguard’s clients have the right to receive dividends or sale proceeds relating to the reported securities, and no single other person’s interest exceeds 5%.
John Wiley & Sons, Inc. disclosed a Form 4 showing a director acquired 144 Phantom Stock Units on 10/23/2025 with Transaction Code A. The units were credited due to a quarterly dividend under the company’s Deferred Compensation Plan for Directors at a reported derivative price of $36.98.
Each unit is 1-for-1 into Class A Common and settles upon separation from the Board. Following this transaction, the director beneficially owned 15,195 derivative securities.
John Wiley & Sons (WLY) director reported acquiring 587 phantom stock units on 10/23/2025, coded “A”. The award resulted from a quarterly dividend credited under the John Wiley & Sons, Inc. Deferred Compensation Plan for Directors and is on a 1-for-1 basis into Class A Common. The filing lists a price of $36.98 for the derivative security.
Following this transaction, the reporting person directly beneficially owns 61,703 derivative securities. These phantom units settle in 100% Class A Common stock upon separation from the Board.
John Wiley & Sons, Inc. reported a director transaction on a Form 4. On 10/23/2025, the director acquired 50 phantom stock units (Transaction Code A). The filing lists a price of derivative security of $36.98 and shows 5,231 derivative securities beneficially owned following the transaction.
The units arose from a quarterly dividend and were deferred under the company’s Deferred Compensation Plan for Directors. Each unit is 1-for-1 with Class A Common stock and will settle in shares upon the director’s separation from the Board.
John Wiley & Sons (WLY): Director Form 4 update. A director acquired 133 Phantom Stock Units on 10/23/2025, credited from a quarterly dividend under the company’s Deferred Compensation Plan for Directors. These units are 1‑for‑1 with Class A Common stock and settle upon separation from the Board. The price of the derivative security was $36.98. Following the transaction, the director beneficially owned 14,008 derivative securities, reported as directly held.